.png){kind=icon}
.png){kind=icon}
Return
High-intensity immunosuppression versus modern standard care in poor-prognosis diffuse cutaneous systemic sclerosis: A propensity-matched study
.png){kind=icon}
OA
AI
L
R
P
Y
Z
J
T
B
A
S
G
R
J
O
A
D
L
B
DOI：10.1016/j.jaut.2026.103594.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Five-year overall survival was similar with HI-IS/HSCT and standard care. • HI-IS/HSCT improved 5-year EFS versus modern standard care (76% vs 46%). • HI-IS/HSCT improved 5-year PFS versus standard care (82% vs 40%). • HI-IS/HSCT stabilized lung function and improved skin fibrosis at 24 months. • Older age and cardiac involvement predicted poorer outcomes after HI-IS/HSCT.
Journal
IF:
7
Papers:
3.1K
Citations:
1.0W
Organization
Cited Papers